Related Experiment Video
Updated: Jul 26, 2025
04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
126
Placenta Accreta Spectrum Disorders: A National Survey
Isabelle Létourneau1, Sebastian R Hobson2, Felipe Moretti3
1Department of Obstetrics, Gynecology and Newborn Care, University of Ottawa, The Ottawa Hospital, Ottawa, ON.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|June 14, 2023
Summary
Canadian obstetricians-gynecologists are increasingly adopting practice guidelines for placenta accreta spectrum (PAS) disorders. Key management strategies include regionalized care, anemia optimization, and cesarean-hysterectomy with placenta in situ.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Surgical Management of Placenta Accreta Spectrum Disorders
Background:
- Placenta accreta spectrum (PAS) disorders pose significant risks to maternal health.
- Effective management requires adherence to evidence-based clinical practice guidelines.
Purpose of the Study:
- To describe current Canadian obstetrician-gynecologist practices for managing PAS disorders.
- To evaluate the impact of the Society of Obstetricians and Gynaecologists of Canada's PAS guidelines on clinical practice.
Main Methods:
- A cross-sectional bilingual electronic survey was distributed to Canadian obstetricians-gynecologists in March-April 2021.
- The 39-item questionnaire collected data on screening, diagnosis, and management of PAS disorders.
- Descriptive statistics were used to analyze the 142 responses.
Main Results:
- Nearly 60% of respondents had read the 2019 SOGC PAS guideline, with almost one-third changing their practice.
- Key management practices adopted include regionalized care, preoperative anemia optimization, cesarean-hysterectomy with placenta in situ (83%), and midline laparotomy (65%).
- Respondents recognized the importance of perioperative blood loss reduction and thromboprophylaxis.
Conclusions:
- The SOGC PAS clinical practice guideline has demonstrably influenced Canadian clinicians' management choices.
- A multidisciplinary approach and regionalized care are crucial for reducing maternal morbidity in PAS disorders.
- Adequate resourcing for maternal-fetal medicine, surgical expertise, transfusion medicine, and critical care is essential.
Related Concept Videos
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
01:24Disorders of the Female Reproductive System
419
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
419